Florbetapir F18
- TRADE NAME: Amyvid (Avid Pharmaceuticals)
- INDICATIONS: Postiron Emission Tomography (PET) imaging
- CLASS: Radiopharmaceutical, diagnostic agent
- HALF-LIFE: 110 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
PREGNANCY CATEGORY: C
Florbetapir F18 injection emits radiation. Use procedures to minimize radiation exposure.
Please login to see the rest of this drug profile
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric